Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
British Journal of Obstetrics and Gynaecology|May 1, 1989
Intraperitoneal radioimmunotherapy for ovarian cancerJ S Stewart, V Hird, M Sullivan, et al.
Journal of Enzyme Inhibition|January 1, 1990
Competitive inhibition of a tumour cell surface protease. A rapid technique for in vitro testing of selective targeting systemsF S Steven, M M Griffin, F B Barnett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapyC Kosmas, A Maraveyas, C S Gooden, et al.
Protein Engineering|January 1, 1997
Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targetingM P Deonarain, G Rowlinson-Busza, A J George, et al.
Scandinavian Journal of Immunology|August 1, 1996
Enhanced in vivo immunogenicity induced by an antibody to the IL-4 receptor-associated gp200-MR6 moleculeG B Sivolapenko, N Imami, M Larché, et al.
The International Journal of Biological Markers|May 1, 1987
Accessibility of antigenic sites recognized by AUA1, HMFG1 and HMFG2 monoclonal antibodies: its influence on antibody binding of live cellsW J Mooi, T Krausz, S C Kirkland, et al.
Cancer Research|August 15, 1987
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factorsN S Courtenay-Luck, A A Epenetos, C G Winearls, et al.
British Journal of Cancer|October 3, 1999
Development of a novel bi-specific monoclonal antibody approach for tumour targetingA A Koumarianou, M Hudson, R Williams, et al.
Lancet (London, England)|November 6, 1982
Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusionsA A Epenetos, G Canti, J Taylor-Papadimitriou, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune responseH P Kalofonos, C Kosmas, V Hird, et al.
Pageof 16